Isomorphic Labs is a drug discovery company that uses predictive and generative artificial intelligence to model biological phenomena and design novel medicines. Building upon the AlphaFold system, the company develops AI-driven tools aimed at accelerating scientific research and treating devastating diseases.
Subscribe to see Isomorphic Labs’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Isomorphic Labs is an ai/ml company headquartered in Switzerland. Xcout tracks 7 named people at Isomorphic Labs, including Max Jaderberg, PhD (President). Xcout recorded 57 job postings from Isomorphic Labs in the last 90 days.
1 more named person on record for Isomorphic Labs, with roles, board committees and tenure — see the full roster →
Xcout recorded 57 job postings from Isomorphic Labs in the last 90 days, from a hiring record Xcout has kept since June 2026.
The weekly hiring trend, the roles and locations behind it — see Isomorphic Labs's hiring signals →
Based on 37 job postings in the last 8 weeks (10 Aug – 4 Oct 2026), compared with 380 scale-up technology companies.
This describes a hiring pattern — how often Isomorphic Labs’s job postings ask for AI skills, and how that changed against the previous 8 weeks, ranked among its peers. It says nothing about the company’s products or performance.
Signed-in members see the AI-skill share and its change with peer percentiles, role mix, posting momentum and advertised US pay against the market.
A few of Isomorphic Labs's closest competitors — see the full list of competitors and alternatives →
Latent Labs Technologies operates as a frontier artificial intelligence laboratory that builds generative models for molecular biology. The company provides AI-driven tools and agents—such as Latent-Y, Latent-X2, and Latent-X—to help researchers and partners design drugs, create antibodies, optimize enzymes, and advance genetic engineering.
Numerion Labs, headquartered in San Francisco, CA, USA, specializes in AI-based drug discovery services. The company employs a world-class team of scientists and engineers to redefine how small-molecule drugs are discovered using artificial intelligence.
Inceptive is a data-driven lab focused on AI medicines, creating tools for the rational design of novel biomolecules and biological software. The company has offices in Palo Alto, Berlin, and Zurich, and is pioneering the next generation of AI-driven medical advancements.
Pathos AI, Inc. is an artificial-intelligence-driven biopharmaceutical company that uses multimodal patient and biological data to discover and develop precision medicines. Its work is focused primarily on oncology and serves patients with serious diseases through pharmaceutical and healthcare partnerships.
BIO-AI, Inc. develops AI-driven world models to simulate human biology across multiple scales. The company builds programmable virtual cells and a general-purpose cell biology simulator to accelerate research and discovery for medicine, biotechnology, and life sciences.
Pepticom operates an artificial intelligence-driven drug discovery platform focused on designing and optimizing novel therapeutic peptides. The company utilizes reinforcement learning, generative AI, and computational algorithms to develop drug candidates for both internal programs and industry collaborations.
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Post the link and the card appears automatically — each network fetches the image itself.